Filters

Brigida Carducci, Valerio De Stefano, Giovanni Vento, Luciana Teofili, Patrizia Papacci, Nicoletta Orlando, Maria Bianchi, Anna Molisso, Velia Purcaro, Caterina Giovanna Valentini, Carmen Giannantonio, Francesca Serrao, Patrizia Chiusolo, Nicola Nicolotti, Claudio Pellegrino

British journal of haematology 2021;191(2):263-268

Full Text

Abstract

Pathophysiology and recent therapeutic insights of sickle cell disease.

Mitesh Dwivedi, Firdosh Shah

Annals of hematology 2020;99(5):925-935

Full Text

Abstract

Lower foetal haemoglobin levels at 31- and 34-weeks post menstrual age is associated with the development of retinopathy of prematurity : PacIFiHER Report No. 1 PacIFiHER Study Group (Preterm Infants and Fetal Haemoglobin in ROP).

Kim Jiramongkolchai, Michael X Repka, Jing Tian, Susan W Aucott, Jennifer Shepard, Megan Collins, Courtney Kraus, Julia Clemens, Mia Feller, Irina Burd, Marina Roizenblatt, Morton F Goldberg, J Fernando Arevalo, Peter Gehlbach, James T Handa

Eye (London, England) 2021;35(2):659-664

Free Full Text

Abstract

Efficacy of curcumin and resveratrol in the synergistic activation of foetal haemoglobin in sickle cell disease.

Robby Kumar, Eli Mohapatra

The Indian journal of medical research 2026;164(1):11-18

Full Text

Abstract

Hemoglobins F, A , and E levels in Laotian children aged 6-23 months with Hb E disorders: Effect of age, sex, and thalassemia types.

Supan Fucharoen, Benchawan Kingchaiyaphum, Kanokwan Sanchaisuriya, Goonnapa Fucharoen, Attawut Chaibunruang, Sonja Y Hess, Guy-Marino Hinnouho, Maxwell A Barffour, Kimbery R Wessells, Sengchanh Kounnavong

International journal of laboratory hematology 2020;42(3):277-283

Free Full Text

Abstract

Modern treatment of thalassaemia intermedia.

Caterina Borgna-Pignatti

British journal of haematology 2007;138(3):291-304

Full Text

Abstract

Results: 1 – 15 / 49

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Fetal Hemoglobin""[mesh_terms]

Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.

The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease.

Fetal globin induction in beta-thalassemia.

Optimal management of β thalassaemia intermedia.

Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.

Anemia: progress in molecular mechanisms and therapies.

Use of genome-editing tools to treat sickle cell disease.

Recent perspectives of pediatric β-thalassemia.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.

Pathophysiology and recent therapeutic insights of sickle cell disease.

Lower foetal haemoglobin levels at 31- and 34-weeks post menstrual age is associated with the development of retinopathy of prematurity : PacIFiHER Report No. 1 PacIFiHER Study Group (Preterm Infants and Fetal Haemoglobin in ROP).

Efficacy of curcumin and resveratrol in the synergistic activation of foetal haemoglobin in sickle cell disease.

Hemoglobins F, A , and E levels in Laotian children aged 6-23 months with Hb E disorders: Effect of age, sex, and thalassemia types.

Modern treatment of thalassaemia intermedia.

Results for
""Fetal Hemoglobin""[mesh_terms]